TruPlan vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

TruPlan

by Circle Cardiovascular Imaging Inc.

Tempus ECG-Low EF

by Tempus

AI Verdict

TruPlan is an AI-enabled CT imaging software focused on comprehensive pre-procedural planning and post-procedural follow-up for Left Atrial Appendage Closure (LAAC) procedures. Conversely, Tempus ECG-Low EF is an AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction and heart failure risk. While both are cardiology AI tools, they address different stages of patient care and utilize distinct data modalities, making them adjacent rather than direct competitors.

Choose TruPlan if…

Choose TruPlan if your clinical practice requires advanced, AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. This tool is ideal for cardiologists and cardiothoracic surgeons needing precise 3D anatomical assessment, automated LAA landing zone definition, and multi-modal simulation capabilities (TEE, ICE, fluoroscopic) to optimize device selection and placement.

View TruPlan →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need an efficient, AI-powered solution for early identification of patients at risk of heart failure by analyzing standard 12-lead ECG recordings. This software is best suited for cardiology, emergency medicine, or internal medicine settings where rapid, non-invasive screening of patients 40 years or older for signs of low left ventricular ejection fraction (LVEF ≤40%) can help prioritize further diagnostic evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	TruPlan	Tempus ECG-Low EF
Deployment	Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection.	Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tempus ECG-Low EF provides a straightforward binary output integrated into existing workflows, suggesting a simpler and more immediately usable tool for a broader range of clinicians. TruPlan, while powerful, involves advanced visualization and simulation tools for specialized procedural planning, implying a steeper learning curve and more complex user interaction.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical needs in cardiology. TruPlan enhances the safety and efficacy of a specific, high-stakes interventional procedure (LAAC), while Tempus ECG-Low EF provides a scalable solution for early detection and risk stratification of a widespread and serious condition (heart failure).

Pricing & Value

TruPlan

While both require contacting the vendor for pricing, TruPlan offers a clearer potential for value through its exclusive resale by Boston Scientific, which may include no additional cost for WATCHMAN procedures. Additionally, its broader cvi42 platform offers a flexible subscription model, suggesting more adaptable pricing structures.

Enterprise Readiness

Tempus ECG-Low EF

Both tools meet essential compliance and regulatory standards, including FDA clearance, HIPAA compliance, and BAA. However, Tempus ECG-Low EF's description of being 'integrated into healthcare facility workflows' suggests a potentially smoother and less burdensome IT integration compared to TruPlan's 'on-premise... thick-client' deployment, which might require more significant IT overhead.

Innovation

TruPlan

TruPlan demonstrates greater innovation through its advanced 3D anatomical assessment and multi-modality simulation capabilities (TEE, ICE, Fluoroscopic Rendering), which provide sophisticated tools for complex interventional procedure planning. Tempus ECG-Low EF is innovative in its application of AI to a common diagnostic test for widespread early disease detection, but TruPlan's features push the boundaries of imaging and procedural simulation.

Support & Docs

TruPlan

Circle Cardiovascular Imaging provides more transparent and detailed information regarding its 'world class support' with a global team offering assistance in multiple languages and time zones. They explicitly list comprehensive documentation for TruPlan, including user manuals and release notes, along with a dedicated support email and ticket system.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	TruPlan	Tempus ECG-Low EF
Product Name	TruPlan	Tempus ECG-Low EF
Company	Circle Cardiovascular Imaging	Tempus AI
Primary Use Case	AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures.	AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Target Medical Condition/Procedure	Left Atrial Appendage Closure (LAAC) procedures	Low Left Ventricular Ejection Fraction (LVEF u226440%) in patients at risk of heart failure
Key AI Functionality	AI-enabled Left Heart Segmentation, Automated LAA Landing Zone Definition, 3D Anatomical Assessment, TEE/ICE/Fluoroscopic Rendering Simulation, Thrombus Assessment Tool	AI-powered algorithm for ECG analysis, detects signs of low LVEF (u226440%), analyzes resting, non-ambulatory 12-lead ECG recordings, provides a binary output (Low LVEF Detected / Not Detected)
Specialties	Cardiology, Cardiothoracic Surgery, Radiology	Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring TruPlan and Tempus ECG-Low EF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for imaging/ECG analysis and patient management, and what is the expected impact on physician efficiency and decision-making?

TruPlan is designed for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, integrating advanced visualization and measurement tools into the workflow of cardiologists, cardiothoracic surgeons, and radiologists. Tempus ECG-Low EF integrates into healthcare facility workflows to analyze 12-lead ECG recordings, providing a binary output that aids clinicians in identifying patients at risk of heart failure for further evaluation, potentially streamlining early detection in cardiology, emergency medicine, and internal medicine settings.

What are the specific performance metrics and clinical validation supporting the reliability of each tool's core functionality?

TruPlan offers AI-enabled left heart segmentation, automated LAA landing zone definition, and 3D anatomical assessment, which are critical for precise procedural planning in LAAC. Tempus ECG-Low EF is an FDA-cleared AI software specifically trained on over 930,000 ECGs from more than 170,000 patients to detect signs associated with low left ventricular ejection fraction (LVEF u226440%), providing a clinically validated binary output to aid in risk identification.

For which specific clinical scenarios or patient populations do these tools offer the most significant clinical advantage or address an unmet need?

TruPlan provides significant advantages for interventional cardiologists and cardiac surgeons by offering detailed pre-procedural planning and simulation for Left Atrial Appendage Closure, enhancing precision and potentially reducing procedural complexities. Tempus ECG-Low EF addresses the need for early identification of heart failure risk by analyzing routine ECGs in patients 40 years or older, allowing for timely intervention and further evaluation in broader clinical settings like emergency medicine and internal medicine.

What is the anticipated learning curve for physicians and support staff to become proficient with each tool, and what training and support resources are provided to facilitate adoption?

TruPlan, with its advanced visualization, 3D anatomical assessment, and simulation features, may involve a moderate learning curve for mastering its comprehensive planning capabilities for LAAC procedures. Tempus ECG-Low EF, providing a binary 'Low LVEF Detected / Not Detected' output from ECG analysis, likely has a simpler learning curve for interpretation within existing diagnostic workflows. Both companies typically offer support and training to ensure effective adoption, though specific details would require direct inquiry.

Beyond standard compliance, what advanced data security protocols are implemented, and what audit-trail features are available to track system usage, data access, and AI-generated insights?

TruPlan, being an on-premise solution, would rely on the hospital's infrastructure security for data protection, with audit trails likely focusing on user actions within the planning software and modifications to patient imaging data. Tempus ECG-Low EF, as integrated software, would have its own protocols for securing ECG data in transit and at rest, and would likely offer audit trails to track the AI analysis process and the generation of low LVEF detection outputs. Specific advanced security measures and audit capabilities beyond HIPAA compliance would need to be detailed by each vendor.

What are the practical considerations and potential challenges for deploying and scaling each solution across multiple hospital sites or a large integrated delivery network?

Deploying TruPlan across multiple sites would involve managing on-premise installations (standalone desktop/laptop or server) at each location, requiring coordination for software installation, maintenance, and potentially data sharing across sites. Tempus ECG-Low EF, as integrated software, might offer a more streamlined multi-site rollout by leveraging existing healthcare facility workflows and potentially centralized management, though integration with diverse ECG systems and EHRs across an IDN would be a key consideration.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring TruPlan or Tempus ECG-Low EF

Backers

Who funded each tool's parent company.